The life science market in the Middle East is undergoing a major transformation, driven by the increasing demand for advanced testing technologies in clinical diagnostics, infectious disease detection, oncology, and personalized medicine. Key technologies fueling life science market segment growth include RT-PCR, conventional PCR, digital PCR (d-PCR), next-generation sequencing (NGS), cell culture, and Western blotting. Backed by regional life science research and technological advancements, this market is attracting significant attention from both global players and local innovators.
According to BIS research, Key Segments in Middle East Life Science Market are:
RT-PCR technology is widely adopted for clinical diagnostics, particularly during the COVID-19 pandemic. It plays a pivotal role in detecting viral infections and genetic diseases. G42 Healthcare has been instrumental in advancing RT-PCR capabilities in the region. Its Biogenix Labs became the first certified high-throughput lab in the Middle East to conduct SARS-CoV-2 genome sequencing using Oxford Nanopore Technologies, enabling rapid variant detection and genomic surveillance. This lab also supports molecular diagnostics for rare diseases.
PCR technology, including conventional and RT-PCR methods, dominates diagnostic applications. The G42-BGI collaboration established a massive-throughput laboratory capable of conducting tens of thousands of RT-PCR tests daily during the COVID-19 pandemic. This lab, built in just 14 days, showcases the UAE's commitment to scaling up testing infrastructure and ensuring reliable diagnostics.
Digital PCR (d-PCR) is gaining recognition for its superior sensitivity and quantification capabilities, particularly in cancer diagnostics and genetic testing. Though still in early stages of adoption in Middle Eastern labs, companies like Bio-Rad Laboratories and QIAGEN are introducing advanced d-PCR platforms tailored for precision applications. As awareness grows, this segment is expected to witness accelerated growth in the coming years.
Next-generation sequencing (NGS) is revolutionizing genomics research in the Middle East. Illumina and Thermo Fisher Scientific lead this market, supported by large-scale genome projects like the Emirati Genome Project and Qatar Genome Project. These initiatives aim to map genetic diversity, improve healthcare outcomes, and reduce hereditary diseases through population-wide sequencing efforts. At Medlab Middle East 2025, PureLab showcased significant advancements in Next-Generation Sequencing (NGS) technologies, emphasizing their commitment to precision medicine. The PureLab Genetic Centre introduced Whole Exome Sequencing (WES) and Targeted Gene Panels, enabling clinicians to tailor treatments for complex diseases.
Cell culture technologies are essential for drug development, vaccine research, and regenerative medicine. The Middle East cell culture market is supported by major providers like GE Healthcare and Thermo Fisher Scientific, supplying advanced media, bioreactors, and lab equipment. With rising investment in biotech and academic research, cell culture adoption is growing across the region.
While newer methods are emerging, Western blotting continues to be a widely used technique in protein analysis and biomarker validation. Key players such as Bio-Rad Laboratories and Cleaver Scientific support Middle Eastern labs with high-quality reagents and instrumentation. This method remains integral to diagnostics and research, particularly in immunology and molecular biology.
Get More Insights on Healthcare Industry
Conclusion
The Middle East life sciences market is on a strong growth trajectory, fueled by innovations in genomics, proteomics, and cell biology. As the region accelerates its shift toward precision medicine and digital healthcare transformation, it is addressing key challenges such as workforce skill gaps and supply chain inefficiencies. Ongoing investments in public-private partnerships, research infrastructure, and biotech innovation are positioning the Middle East as an emerging global hub for life sciences and healthcare technology.
If you need in-depth data on different regions or specific market segments, BIS Research offers custom research services, delivering market intelligence solutions with data-driven insights on emerging technologies, evolving business models, and competitive landscapes to support strategic decision-making in the healthcare industry.
